News | March 14, 2024
Zydus launches generic version of Olaparib ‘IBYRA’ in India
The drug will target specific genetic mutations prevalent in certain types of cancers
The drug will target specific genetic mutations prevalent in certain types of cancers
It is the first autotaxin inhibitor to be investigated in cancer patients
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
According to GlobalData’s analyst consensus forecast, OTX-2002 is projected to have the highest revenue by 2028, with sales of $1.6 billion during that year
The safety profile of KEYTRUDA plus LENVIMA was consistent with previously reported data on the combination.
Dxcover announced that it will be presenting new data at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, June 3-7
As part of large-scale clinical studies prior to market introduction, the AI software has now gone into clinical test with patients, so-called first-in-human applications
City of Hope is first in world to test oncolytic virus, CF33-hNIS, in people with metastatic solid tumours
As an industrial partner of the IHU, the Medi-Globe Group is thus further expanding its role as an innovation leader in minimally invasive diagnostics and therapies
Subscribe To Our Newsletter & Stay Updated
